COGNITIVE impairment risk appears elevated in patients with rheumatoid arthritis, with long-term data showing higher incidence compared with matched controls, reinforcing the need for clinicians to consider cognitive health as part of routine disease management.
Cognitive Impairment and Rheumatoid Arthritis Link
Cognitive impairment can significantly affect daily functioning, treatment adherence, and long-term outcomes. While previous studies have produced mixed findings, large-scale evidence has been limited. Researchers therefore examined whether patients with rheumatoid arthritis face a higher risk of developing cognitive impairment than individuals without the condition.
Nationwide Cohort Design Assessing Cognitive Impairment
This population-based matched cohort study used a Korean nationwide claims database to identify 26,437 patients newly diagnosed with rheumatoid arthritis between 2011 and 2014, alongside 26,437 matched controls based on age, sex, and index year. Follow-up continued from diagnosis to incident cognitive impairment or December 2022. Cognitive impairment was defined using ICD-10 codes including F00 to F03, F31.82, F06.7, G30, and G31.00. Primary outcomes were incidence rates per 1000 person-years and adjusted subdistribution hazard ratios using competing risks regression, accounting for death.
Higher Cognitive Impairment Rates Observed in RA
During mean follow-up of 9.410±2.271 years for rheumatoid arthritis patients and 9.508±2.217 years for controls, 2,952 patients with rheumatoid arthritis (11.17%) and 2,388 controls (9.03%) developed cognitive impairment. Incidence rates were 11.493 per 1000 person-years (95% CI 7.648 to 15.338) in rheumatoid arthritis and 9.219 per 1000 person-years (95% CI 5.386 to 13.052) in controls. Adjusted analyses showed a higher risk of cognitive impairment in rheumatoid arthritis, with subdistribution hazard ratio 1.222 (95% CI 1.171 to 1.275).
Implications for Clinical Practice and Research
These findings suggest cognitive impairment should be considered an important comorbidity in rheumatoid arthritis care. Routine cognitive screening and longitudinal monitoring may help identify at-risk patients earlier. Future research should investigate underlying mechanisms, including inflammation and disease activity, and evaluate strategies to reduce cognitive decline in this population.
Reference
Kwon OC et al. Cognitive impairment risk in patients with rheumatoid arthritis: a population-based cohort study. RMD Open. 2026;12:e006685.
Featured image: peterschreiber.media on Adobe Stock
